Shots: The approval is based on P-III IMpower133 study assessing Tecentriq (atezolizumab) + CT (carboplatin and etoposide) vs CT as monothx. in 403 patients in ratio (1:1) in CT-naïve patients […]readmore
Tags : Initial Treatment